skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
01/12/2021
Application #:
16223538
Filing Dt:
12/18/2018
Publication #:
Pub Dt:
06/20/2019
Inventors:
Alexander HIRD, Wenzhan YANG, Daniel ROBBINS, Steven KAZMIRSKI, Dedong WU, Bo PENG et al
Title:
MCL-1 INHIBITORS AND METHODS OF USE THEREOF
Assignment: 1
Reel/Frame:
048209/0171Recorded: 02/01/2019Pages: 26
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/08/2017
Exec Dt:
02/07/2017
Exec Dt:
02/08/2017
Exec Dt:
02/08/2017
Exec Dt:
02/08/2017
Exec Dt:
02/07/2017
Exec Dt:
02/08/2017
Exec Dt:
02/10/2017
Exec Dt:
02/14/2017
Exec Dt:
02/08/2017
Exec Dt:
02/08/2017
Exec Dt:
02/08/2017
Assignee:
1800 CONCORD PIKE
P.O. BOX 15437
WILMINGTON, DELAWARE 19850-5437
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878
Assignment: 2
Reel/Frame:
048219/0065Recorded: 02/01/2019Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
02/20/2017
Assignee:
2 KINGDOM STREET
LONDON, ENGLAND W2 6BD
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878
Assignment: 3
Reel/Frame:
048228/0241Recorded: 02/01/2019Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
02/24/2017
Assignee:
SE-151 85
SODERTALJE, SWEDEN
Correspondent:
ASTRAZENECA PHARMACEUTICALS
ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878

Search Results as of: 04/30/2024 07:00 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT